The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Informa UK Limited - Tập 16 Số 4 - Trang 313-328 - 2017
Ray Borrow1, Pedro Alarcón2, Josefina Carlos3, Dominique A. Caugant4, Hannah Christensen5, Roberto Debbag6, Philippe De Wals7, Gabriela Echániz-Avilés8, Jamie Findlow1, Chris Head9, Daphné Holt10, Hajime Kamiya11, Samir K. Saha12, Sidorenko Sv13, Muhamed‐Kheir Taha14, Caroline Trotter15, Julio A. Vázquez16, Anne von Gottberg17, Marco Aurélio Palazzi Sáfadi18
1Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK
2Laboratory Gram - Positive Coccus, Instituto de Salud Pública de Chile, Santiago, Chile
3Department of Pediatrics, College of Medicine, University of the East – Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines
4Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway;
5School of Social and Community Medicine, University of Bristol, Bristol, UK
6Pediatric Telemedicine Service, Malvinas Children’s Hospital, Buenos Aires, Argentina
7Department of Social and Preventive Medicine, Laval University, Quebec City, QC, Canada
8Center for Infectious Disease Research, Instituto Nacional de Salud Pública, Cuernavaca, Mexico
9Meningitis Research Foundation, Thornbury, UK
10Governing Council, Confederation of Meningitis Organisations, Head Office, Bristol, UK
11Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
12Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh
13Infectious Disease Surveillance Center, Scientific Research Institute of Children’s Infections, St Petersburg, Russia
14Department of Infection & Epidemiology, Institut Pasteur, Paris, France
15Department of Veterinary Medicine, University of Cambridge, Cambridge, UK
16Meningococcal Reference Laboratory, Institute of Health Carlos III, Madrid, Spain
17Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa
18Department of Pediatrics, FCM da Santa Casa de São Paulo, São Paulo, Brazil

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1084/jem.10.5.690

Centers for Disease Control and Prevention, 2016, Epidemiology and prevention of vaccine-preventable diseases, 13

10.4103/0255-0857.19888

10.1179/2047773213Y.0000000119

10.1111/j.1708-8305.2010.00448.x

10.1016/S0264-410X(01)00205-5

Pollard AJ, 2004, Pediatr Infect Dis J, 23, S274, 10.1097/01.inf.0000147642.85129.05

10.2223/JPED.1495

10.1080/21645515.2015.1108502

10.1016/j.vaccine.2011.12.062

10.1016/j.vaccine.2011.02.058

National Advisory Committee on Immunization (NACI), 2009, Can Commun Dis Rep, 35, 1

Bilukha OO, 2005, MMWR Recomm Rep, 54, 1

10.1086/649209

10.1016/j.trstmh.2007.06.012

Kimmel SR, 2005, Am Fam Physician, 72, 2049

10.1099/jmm.0.45529-0

10.1016/S1473-3099(10)70251-6

10.1016/S1473-3099(07)70288-8

10.1016/j.vaccine.2009.04.061

10.1111/1469-0691.12647

10.1016/j.vaccine.2011.12.032

10.1016/j.mib.2014.11.006

10.1186/1471-2458-12-1062

Chang Q, 2012, Clin Epidemiol, 4, 237

10.4161/hv.24129

Folaranmi T, 2015, MMWR Morb Mortal Wkly Rep, 64, 608

10.15585/mmwr.mm6441a3

10.1016/j.vaccine.2013.04.003

10.1586/14760584.2013.814879

10.1586/14760584.2015.979799

10.1016/j.vaccine.2015.10.055

10.1017/S0950268816001308

10.1016/j.jinf.2015.07.007

10.1093/jpids/piu027

10.1097/INF.0000000000000853

10.3201/eid2005.130948

10.1186/1478-7954-11-17

10.11150/kansenshogakuzasshi1970.79.527

10.1016/j.jiac.2015.12.016

10.1016/j.jiac.2015.03.006

European Centre for Disease Prevention and Control, 2015, Surveillance of invasive bacterial diseases in Europe, 2012

10.1016/j.vaccine.2013.07.083

Koroleva I, 2014, Meningococcal infection and purulent bacterial meningitis in Russia: analytical review

Matosova SV, 2016, Epidemiologia I Infekcionnye Bolezni, 4

10.1086/525260

10.1097/QAD.0b013e32833a2520

10.1186/s12916-015-0538-6

Ibarz-Pavón AB, Morais L, Sigaúque B, 2011, PLoS One, 6

Murray J, 2014, MMWR Morb Mortal Wkly Rep, 63, 1159

10.4161/hv.22302

10.1086/527401

10.1136/bmj.326.7385.365

10.1093/cid/cis892

10.1016/S0140-6736(13)61612-8

10.1016/j.jinf.2015.02.006

10.1371/journal.pone.0046019

10.3201/eid2210.160468

10.1093/cid/civ597

10.1093/cid/civ508

Global Advisory Committee on Vaccine Safety, 2010, Wkly Epidemiol Rec, 85, 29

World Health Organization, 2015, Wkly Epidemiol Rec, 90, 123

World Health Organization website [Internet], 2014, World Health Organization Strategic Advisory Group of Experts (SAGE) on Immunization

World Health Organization, 2015, Wkly Epidemiol Rec, 90, 633

10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518

10.1016/S0140-6736(00)03502-9

10.1128/JCM.40.3.1083-1084.2002

10.1086/340414

10.1016/j.patbio.2007.10.005

10.1016/j.jinf.2009.11.014

10.1016/j.jinf.2008.07.014

10.4067/S0034-98872013000800001

10.1017/S0950268814001149

10.1016/j.ebiom.2015.09.007

10.1093/cid/ciu881

10.1016/S0140-6736(12)61961-8

10.1007/s40259-015-0139-0

10.1073/pnas.1013758107

10.1016/j.vaccine.2012.12.022

Patel M, 2014, Use of a novel serogroup B meningococcal vaccine in response to two university outbreaks in the US. XIXth International Pathogenic Neisseria Conference

10.1542/peds.2014-4015

10.1016/j.vaccine.2015.04.015

10.1186/s12866-015-0469-6

de Wals P, 2015, Results of a mass immunization campaign with a 4-components serogroup B meningococcal vaccine in Quebec, Canada

10.1016/j.vaccine.2013.06.080

10.1177/0272989X05284109

10.1016/S0140-6736(14)60842-4

10.1093/aje/kwi160

10.1016/j.vaccine.2013.03.034

10.1016/j.vaccine.2016.02.014

10.1586/erv.09.48

10.1371/journal.pone.0154047